COVID-19 Educational Materials for Reducing School Absenteeism

(ROSSEY Trial)

Overseen By Miriana Duran

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: University of Washington

Disqualifiers: Incarceration, Dementia, Terminal illness, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

1095 Participants Needed

Trial Summary

What is the purpose of this trial?

The study has three aims and involves a clustered randomized controlled trial (RCT) where K-5 schools will be the unit of randomization. Aim 1 involves a qualitative assessment of rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain onsite learning. Aim 2 includes a clustered RCT in schools. Aim 3 involves qualitative assessment of implementation outcomes of the Yakima School District (YSD) testing program and risk communication intervention with school stakeholders, parents, and children.

Research Team

Linda Ko, PhD, MPH

Principal Investigator

University of Washington

Eligibility Criteria

This study is for K-5 students and staff at participating schools who can attend in-person at least twice a week. They must be willing to follow the study's rules, including weekly online check-ins and interviews, have reliable internet access, and speak English or Spanish. Those with severe health issues or impairments that limit participation are excluded.

Inclusion Criteria

Participant attends or works in a participating school for at least 2 days/week

Participant must be willing to comply with all study procedures, including weekly online check-ins and phone interviews

Participant should have consistent and reliable Internet access, either by smart phone or computer

Exclusion Criteria

Individuals who are incarcerated

Individuals with conditions that may preclude or limit the participant's ability to comply with study procedures, according to the investigators

I can give my consent or have someone legally authorized to do so on my behalf.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pilot Study

Conducting weekly novel coronavirus surveillance testing in one school to understand implementation steps and workflow

12 weeks

Weekly visits

Clustered RCT

Evaluate the effectiveness of risk communication on student attendance and participation in SARS-CoV-2 testing

18 months

Regular intervals for intervention delivery

Follow-up

Participants are monitored for absenteeism and secondary outcomes such as emotional regulation and perceived stress

9 months

Treatment Details

Interventions

• COVID-19 Health Education Comic Books and Videos
• SARS-CoV-2 testing

Trial Overview The trial is testing COVID-19 educational materials like comic books and videos in schools to see if they help reduce absenteeism. Schools are randomly chosen to either use these materials or not, and researchers will compare the results between these groups.

Participant Groups

Group I: COVID-19 Comic Books and Videos Active Control 1 Intervention

This arm will include schools that are randomized to receive the health education with comic books and videos focused on the benefits of preventive measures for COVID-19.

Group II: Control Group Active Control 1 Intervention

This arm will include schools and the enrolled families assigned as the control group, who will not receive the COVID-19 health education comic books and video intervention.

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials

1,858

Recruited

2,023,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials

2,103

Recruited

2,760,000+